YU241279 is an orally active CXCR5 inhibitor. YU241279 inhibits CXCL13-mediated Galphaq-dependent calcium influx and Galphai2-dependent cAMP reduction in CXCR5-expressing cells. YU241279 inhibits the proliferation of CXCR5-expressing lymphoma cells. YU241279 reduces tumor burden in the peripheral blood and bone marrow of mice implanted with lymphoma tissues. YU241279 is well tolerated during oral administration in mice, maintains stable plasma drug concentrations, and shows no metabolic changes. YU241279 can be used in the research of angioimmunoblastic T-cell lymphoma and Burkitt B-cell lymphoma[1].
Molekulargewicht:
351.44
Reinheit:
99.58
CAS Nummer:
[1092445-63-0]
Formel:
C22H25NO3
Target-Kategorie:
CXCR
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
